Glucose and insulin administration while maintaining normoglycemia: the GIN concept

Area of Science:

• Critical Care Medicine
• Endocrinology
• Surgical Patient Management

Background:

• The benefits of tight glucose control in critically ill and surgical patients are debated.
• Intensive insulin therapy has shown mixed results regarding survival benefits.
• Conventional insulin sliding scale protocols present challenges in achieving normoglycemia and carry risks of hypoglycemia.

Purpose of the Study:

• To examine the efficacy and potential benefits of hyperinsulinemic-normoglycemic clamping, or glucose-insulin-normoglycemia (GIN) therapy.
• To explore GIN therapy as a novel approach for achieving normoglycemia in the perioperative period.
• To discuss the potential reduction in morbidity and mortality associated with hyperglycemia through GIN therapy.

Main Methods:

• Review and examination of hyperinsulinemic-normoglycemic clamping (GIN) therapy.
• Analysis of GIN therapy's application in the perioperative setting.
• Discussion of pharmacological advantages conferred by hyperinsulinemia during GIN therapy.

Main Results:

• GIN therapy, when properly applied, has the potential to reduce morbidity and mortality linked to hyperglycemia.
• The therapy offers pharmacological benefits associated with hyperinsulinemia.
• Current challenges include difficulties in achieving consistent normoglycemia and concerns about severe hypoglycemia with conventional methods.

Conclusions:

• GIN therapy presents a promising approach to managing perioperative hyperglycemia.
• Further research into molecular mechanisms and development of continuous glucose monitoring devices are needed for routine clinical adoption.
• GIN therapy may offer significant advantages over conventional methods for glucose control in high-risk patient populations.